Canlyniadau Chwilio - Amos D. Korczyn

Mireinio'r Canlyniadau
  1. 1
    Dementia in the COVID-19 Period

    Dementia in the COVID-19 Period gan Amos D. Korczyn

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Carta
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Are dementia with Lewy bodies and Parkinson’s disease dementia the same disease?

    Are dementia with Lewy bodies and Parkinson’s disease dementia the same disease? gan K. A. Jellinger, Amos D. Korczyn

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Cerebral amyloid angiopathy impact on endothelium

    Cerebral amyloid angiopathy impact on endothelium gan Lea T. Grinberg, Amos D. Korczyn, Helmut Heinsen

    Cyhoeddwyd 2012
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Auditory hallucinations in Parkinson's disease

    Auditory hallucinations in Parkinson's disease gan Rivka Inzelberg, Svetlana Kipervasser, Amos D. Korczyn

    Cyhoeddwyd 1998
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Vascular dementia

    Vascular dementia gan Amos D. Korczyn, Veronika Vakhapova, Lea T. Grinberg

    Cyhoeddwyd 2012
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    EEG in demented and non-demented parkinsonian patients

    EEG in demented and non-demented parkinsonian patients gan M. Y. Neufeld, Rivka Inzelberg, Amos D. Korczyn

    Cyhoeddwyd 1988
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    ApoE4: an emerging therapeutic target for Alzheimer’s disease

    ApoE4: an emerging therapeutic target for Alzheimer’s disease gan Mirna Safieh, Amos D. Korczyn, Daniel M. Michaelson

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model.

    Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model. gan Lea Ziporen, Yehuda Shoenfeld, Yair Levy, Amos D. Korczyn

    Cyhoeddwyd 1997
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Female sexuality in multiple sclerosis: the multidimensional nature of the problem and the intervention

    Female sexuality in multiple sclerosis: the multidimensional nature of the problem and the intervention gan Gila Bronner, Einat Elran, J Golomb, Amos D. Korczyn

    Cyhoeddwyd 2010
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Can Biomarkers Help the Early Diagnosis of Parkinson’s Disease?

    Can Biomarkers Help the Early Diagnosis of Parkinson’s Disease? gan Weidong Le, Jie Dong, Song Li, Amos D. Korczyn

    Cyhoeddwyd 2017
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Quality of life in Parkinson's disease: A gender‐specific perspective

    Quality of life in Parkinson's disease: A gender‐specific perspective gan Yacov Balash, Amos D. Korczyn, Angel A. Migirov, Tanya Gurevich

    Cyhoeddwyd 2019
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Disorders of the Oral Cavity in Parkinson’s Disease and Parkinsonian Syndromes

    Disorders of the Oral Cavity in Parkinson’s Disease and Parkinsonian Syndromes gan Yair Zlotnik, Yacov Balash, Amos D. Korczyn, Nir Giladi, Tanya Gurevich

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Inheritance of idiopathic torsion dystonia among Jews.

    Inheritance of idiopathic torsion dystonia among Jews. gan Nelly Zilber, Amos D. Korczyn, Esther Kahana, K. Fried, Milton Alter

    Cyhoeddwyd 1984
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Diabetes and the brain: issues and unmet needs

    Diabetes and the brain: issues and unmet needs gan Natan M. Bornstein, Michael Brainin, Alla Guekht, Ingmar Skoog, Amos D. Korczyn

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    ACE, MTHFR, Factor V Leiden, and APOE Polymorphisms in Patients With Vascular and Alzheimer’s Dementia

    ACE, MTHFR, Factor V Leiden, and APOE Polymorphisms in Patients With Vascular and Alzheimer’s Dementia gan Joab Chapman, Ningshan Wang, T. A. Treves, Amos D. Korczyn, Natan M. Bornstein

    Cyhoeddwyd 1998
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin)

    ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin) gan Alla Guekht, Ingmar Skoog, Sally Edmundson, В. В. Захаров, Amos D. Korczyn

    Cyhoeddwyd 2017
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    Subjective memory complaints in elders: depression, anxiety, or cognitive decline?

    Subjective memory complaints in elders: depression, anxiety, or cognitive decline? gan Yacov Balash, M. Mordechovich, H. Shabtai, Nir Giladi, Tanya Gurevich, Amos D. Korczyn

    Cyhoeddwyd 2012
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    Rivastigmine (Exelon) for dementia in patients with Parkinson's disease

    Rivastigmine (Exelon) for dementia in patients with Parkinson's disease gan Nir Giladi, H. Shabtai, Tanya Gurevich, B. R. Benbunan, M. Anca, Amos D. Korczyn

    Cyhoeddwyd 2003
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    A Randomised, Double-Blind, Placebo-Controlled Trial of Actovegin in Patients with Post-Stroke Cognitive Impairment: ARTEMIDA Study Design

    A Randomised, Double-Blind, Placebo-Controlled Trial of Actovegin in Patients with Post-Stroke Cognitive Impairment: ARTEMIDA Study Design gan Alla Guekht, Ingmar Skoog, Amos D. Korczyn, В. В. Захаров, Martin Eeg, Ulf Vigonius

    Cyhoeddwyd 2013
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    Clinical heterogeneity and unusual presentations of Creutzfeldt-Jakob disease in Jewish patients with the PRNP codon 200 mutation.

    Clinical heterogeneity and unusual presentations of Creutzfeldt-Jakob disease in Jewish patients with the PRNP codon 200 mutation. gan Joab Chapman, Paul Brown, L. G. Goldfarb, A Arlazoroff, D. Carleton Gajdusek, Amos D. Korczyn

    Cyhoeddwyd 1993
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: